MREO 8-K 2026-01-12

Mereo BioPharma Group plc (MREO) 8-K dated 2026-01-12 — accession 0001193125-26-009829. This URL is the filing, not the MREO hub.

Mereo BioPharma Group plc (MREO) is a biotechnology company listed on US.

Mereo BioPharma Group plc filed a 8-K on 2026-01-12. Accession 0001193125-26-009829.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.

Not investment advice. The MREO SEC hub lists recent forms. The stock page is the research view.